Generation of rat monoclonal antibodies against murine PTA1/CD226

Hybridoma (Larchmt). 2007 Apr;26(2):73-7. doi: 10.1089/hyb.2006.042.

Abstract

PTA1 (platelet and T cell antigen 1), designated as CD226, is one of the major activating receptors on NK cells. PTA1/CD226 is also broadly expressed on a variety of hematopoietic cells, including Th cells, CTLs, NK T cells, monocytes, DCs, and mast cells, and is involved in multiple immunoregulation. Murine PTA1 (mPTA1) is the homolog molecule of human PTA1. Using mPTA1-Fc as immunogen and the technique of rat B lymphocyte hybridoma, we raised five hybridoma cell lines secreting monoclonal antibodies (MAbs) to mPTA1, designated FMU-mCD226.1 approximately FMU-mCD226.5. Rat immunoglobulin class and subclass of the MAbs FMU-mCD226.1 approximately 5 were determined to be IgG2a, IgM, IgM, IgG1, and IgG1, respectively. FMU-mCD226.2, 3, 4, and 5 worked well in Western blot assay and could also recognize natural PTA1 on the surface of EL-4 cells and mPTA1 cDNA transfected 293T cells detected by FCM. Thus, successful production of rat anti-murine PTA1/CD226 monoclonal antibodies provides a new powerful tool for investigation of murine PTA1 function in the mouse model, both in vitro and in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / biosynthesis*
  • Antibodies, Monoclonal / isolation & purification
  • Antigens, Differentiation, T-Lymphocyte / immunology*
  • Cell Line
  • Cell Membrane / immunology
  • Female
  • Humans
  • Hybridomas
  • Mice
  • Rabbits
  • Rats
  • Recombinant Fusion Proteins / immunology

Substances

  • Antibodies, Monoclonal
  • Antigens, Differentiation, T-Lymphocyte
  • CD226 antigen
  • Recombinant Fusion Proteins